Danaher Life Sciences and Agilent Technology joined existing backers Merck Group and Illumina for a $50m series B extension that increased the round’s total to nearly $89m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Indigo Diabetes increased its total funding to $52.6m with a series B round backed by Ackermans & van Haaren.

Enthera Pharmaceuticals was co-founded by faculty from University of Milan and is using stem cells to treat autoimmune disorders.

CureVac has filed for an initial public offering in the US, 20 years after being spun out of Eberhard Karls University of Tübingen.

Forbes-backed online pharmacy Ro has received $200m in funding led by General Catalyst, trebling its valuation to $1.5bn.

IU Philanthropic Venture Fund returned for a series A round expected to help MBX identify clinical-stage peptides for rare endocrine genetic diseases.

GlaxoSmithKline is in line for an exit as CureVac files for an initial public offering in the US, 20 years after being spun out of Eberhard Karls University of Tübingen.

Indigo Diabetes increased its total funding to $52.6m with a series B round backed by Imec.xpand and returning investor Qbic.

AbbVie Ventures and Sofinnova Partners have co-led a series A round for Enthera Pharmaceuticals, which is using stem cells to treat autoimmune disorders.